Open AccessA Short Note on the General Aspects of Drug Designing
Author(s) -
Rafidah Md Noor
Publication year - 2021
Publication title -
open access journal of microbiology and biotechnology (oajmb)
Language(s) - English
Resource type - Journals
ISSN - 2576-7771
DOI - 10.23880/oajmb-16000184
Subject(s) - variety (cybernetics) , globe , risk analysis (engineering) , clinical trial , engineering ethics , drug , management science , computer science , intensive care medicine , medicine , data science , biochemical engineering , engineering , pharmacology , artificial intelligence , pathology , ophthalmology
Emerging and re-emerging diseases are expanding round the globe which drew the mass public health in dreadful condition. Microbial resistance to drugs is a complicated issue for the failure of treatment of a variety of diseases. In this circumstance, designing of appropriate drug(s) is essential which usually involves the computational modeling and simulation followed by cell culture/ animal model experiments, ending up to clinical trials. Current review briefly focused on the general aspects of drug manufacturing; and a short discussion on the fine tune basis of drug designing grounded on the previously published literature.